{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:27:55Z","timestamp":1793726875197,"version":"4.6.1"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"\n Importance<\/jats:title>\n Preliminary studies suggest heart rate variability biofeedback (HRVB) may reduce craving and negative affect in individuals with substance use disorder (SUD), but few studies have evaluated whether this translates into improved substance use outcomes, and no prior studies have examined second-generation wearable HRVB technology in this context.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the effects of second-generation HRVB on negative affect, positive affect, craving, and alcohol and other drug (AOD) use in adults with SUD.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This phase 2 randomized clinical trial included 8 weeks of outpatient treatment. Recruitment was conducted virtually across the US from February 2023 to June 2024. Treatment-seeking adults with SUD were randomized to receive HRVB\u2009+\u2009treatment as usual (TAU) or TAU only.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Eight weeks of HRVB.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were negative affect, positive affect, craving, and substance use, assessed with ecological momentary assessment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 260 individuals assessed for eligibility, 120 were randomized to receive HRVB\u2009+\u2009TAU or TAU only. Among study participants (69 female participants of 115 [60.0%]; mean [SD] age, 46.18 [11.59] years), HRVB was associated with significant reductions in negative affect (\n b<\/jats:italic>\n , \u20130.01;\n z<\/jats:italic>\n , \u20133.21;\n P<\/jats:italic>\n \u2009=\u2009.001) and craving (\n b<\/jats:italic>\n , \u20130.01;\n z<\/jats:italic>\n , \u20134.60;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) over 8 weeks. In contrast, the control group experienced increases in both negative affect and craving. No differences were observed for positive affect. HRVB was also associated with a significantly lower proportion of AOD use days (odds ratio [OR], 0.36; 95% credible interval [CrI], 0.25-0.54), representing a 64% reduction in AOD use compared to controls. Treatment condition moderated the within-person relationship between craving and later AOD use (OR, 0.84; 95% CrI, 0.73-0.97), such that those receiving HRVB were less likely to use AOD following craving (\n b<\/jats:italic>\n , \u20130.18; 95% CrI, \u20130.32 to \u20130.03).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this randomized clinical trial, findings suggest second-generation HRVB can reduce negative affect, craving, and substance use among individuals in early recovery from SUD. HRVB appears to confer benefit in part by disrupting the association between craving and subsequent AOD use; these results support HRVB as a potentially efficacious treatment for SUD and warrant further investigation in phase 3 trials.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05454657<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2025.2700","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:01:01Z","timestamp":1759330861000},"page":"1177","source":"Crossref","is-referenced-by-count":8,"title":["Heart Rate Variability Biofeedback for Substance Use Disorder"],"prefix":"10.1001","volume":"82","author":[{"given":"David","family":"Eddie","sequence":"first","affiliation":[{"name":"Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital, Boston"},{"name":"Department of Psychiatry, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Zeng","sequence":"additional","affiliation":[{"name":"Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mei","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Emery","sequence":"additional","affiliation":[{"name":"Department of Psychology, Colorado State University, Fort Collins"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"yoi250050r1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.15585\/mmwr.mm7308a1","article-title":"Deaths from excessive alcohol use - United States, 2016-2021.","volume":"73","author":"Esser","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"yoi250050r4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1037\/0021-843X.106.2.243","article-title":"Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.","volume":"106","author":"Cooney","year":"1997","journal-title":"J Abnorm Psychol"},{"issue":"5335","key":"yoi250050r5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.278.5335.52","article-title":"Drug abuse: hedonic homeostatic dysregulation.","volume":"278","author":"Koob","year":"1997","journal-title":"Science"},{"issue":"5","key":"yoi250050r6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11920-007-0050-6","article-title":"The role of stress in addiction relapse.","volume":"9","author":"Sinha","year":"2007","journal-title":"Curr Psychiatry Rep"},{"issue":"2","key":"yoi250050r7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1037\/0033-295X.97.2.147","article-title":"A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes.","volume":"97","author":"Tiffany","year":"1990","journal-title":"Psychol Rev"},{"issue":"3","key":"yoi250050r8","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s40429-021-00379-3","article-title":"Substance use and addiction affect more than the brain: the promise of neurocardiac interventions.","volume":"8","author":"Eddie","year":"2021","journal-title":"Curr Addict Rep"},{"issue":"2","key":"yoi250050r9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10484-006-9009-3","article-title":"Characteristics of resonance in heart rate variability stimulated by biofeedback.","volume":"31","author":"Vaschillo","year":"2006","journal-title":"Appl Psychophysiol Biofeedback"},{"issue":"3","key":"yoi250050r10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1023\/A:1009554825745","article-title":"Resonant frequency biofeedback training to increase cardiac variability: rationale and manual for training.","volume":"25","author":"Lehrer","year":"2000","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"yoi250050r11","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fpsyt.2019.00624","article-title":"Resonance-paced breathing alters neural response to visual cues: proof-of-concept for a neuroscience-informed adjunct to addiction treatments.","volume":"10","author":"Bates","year":"2019","journal-title":"Front Psychiatry"},{"key":"yoi250050r12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.copsyc.2019.03.008","article-title":"Theoretical implications and clinical support for heart rate variability biofeedback for substance use disorders.","volume":"30","author":"Leyro","year":"2019","journal-title":"Curr Opin Psychol"},{"issue":"4","key":"yoi250050r13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/16066359.2015.1011625","article-title":"Heart rate variability biofeedback: theoretical basis, delivery, and its potential for the treatment of substance use disorders.","volume":"23","author":"Eddie","year":"2015","journal-title":"Addict Res Theory"},{"issue":"1","key":"yoi250050r14","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12958","article-title":"Closing the brain-heart loop: towards more holistic models of addiction and addiction recovery.","volume":"27","author":"Eddie","year":"2022","journal-title":"Addict Biol"},{"issue":"3-4","key":"yoi250050r15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10484-014-9251-z","article-title":"A pilot study of brief heart rate variability biofeedback to reduce craving in young adult men receiving inpatient treatment for substance use disorders.","volume":"39","author":"Eddie","year":"2014","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"yoi250050r16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.alcohol.2017.02.200","article-title":"Anxiety, depression, and stress in a high-risk college environment: improving heart rate variability and neurocardiac signaling to prevent relapse.","volume":"60","author":"Eddie","year":"2017","journal-title":"Alcohol"},{"key":"yoi250050r17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addbeh.2019.05.005","article-title":"Substance craving changes in university students receiving heart rate variability biofeedback: a longitudinal multilevel modeling approach.","volume":"97","author":"Alayan","year":"2019","journal-title":"Addict Behav"},{"issue":"1","key":"yoi250050r18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12888-017-1480-2","article-title":"Effect of short-term heart rate variability biofeedback on long-term abstinence in alcohol dependent patients - a one-year follow-up.","volume":"17","author":"Penzlin","year":"2017","journal-title":"BMC Psychiatry"},{"key":"yoi250050r19","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2147\/NDT.S84798","article-title":"Heart rate variability biofeedback in patients with alcohol dependence: a randomized controlled study.","volume":"11","author":"Penzlin","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"yoi250050r20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10484-009-9085-2","article-title":"The effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: a pilot study.","volume":"34","author":"Zucker","year":"2009","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"yoi250050r21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jsat.2018.06.014","article-title":"Assessing heart rate variability biofeedback as an adjunct to college recovery housing programs.","volume":"92","author":"Eddie","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"yoi250050r22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/acp.1750","article-title":"The effect of short duration heart rate variability (HRV) biofeedback on cognitive performance during laboratory induced cognitive stress.","volume":"25","author":"Prinsloo","year":"2011","journal-title":"Appl Cogn Psychol"},{"issue":"10","key":"yoi250050r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046597","article-title":"Matter over mind: a randomised-controlled trial of single-session biofeedback training on performance anxiety and heart rate variability in musicians.","volume":"7","author":"Wells","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"yoi250050r24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"4","key":"yoi250050r28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress.","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"issue":"2","key":"yoi250050r29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/smi.2592","article-title":"Confirmatory factor analysis of the Perceived Stress Scale-4 in a community sample.","volume":"32","author":"Ingram","year":"2016","journal-title":"Stress Health"},{"issue":"3","key":"yoi250050r30","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.3928\/24748307-20190626-01","article-title":"Interview administration of PROMIS depression and anxiety short forms.","volume":"3","author":"Taple","year":"2019","journal-title":"Health Lit Res Pract"},{"issue":"7","key":"yoi250050r31","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1111\/acer.14854","article-title":"Emotion differentiation in early recovery from alcohol use disorder: associations with in-the-moment affect and 3-month drinking outcomes.","volume":"46","author":"Emery","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"issue":"5","key":"yoi250050r32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1037\/adb0000561","article-title":"Why don\u2019t they stop? understanding unplanned marijuana use among adolescents and young adults.","volume":"34","author":"Emery","year":"2020","journal-title":"Psychol Addict Behav"},{"issue":"8","key":"yoi250050r33","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00213-013-3372-6","article-title":"Alcohol craving in adolescents: bridging the laboratory and natural environment.","volume":"231","author":"Ramirez","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"yoi250050r34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addbeh.2019.01.033","article-title":"A review of EMA assessment period reporting for mood variables in substance use research: expanding existing EMA guidelines.","volume":"94","author":"Singh","year":"2019","journal-title":"Addict Behav"},{"issue":"5","key":"yoi250050r35","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/acer.70035","article-title":"Examining the moment-to-moment association between drinking and problems: the moderating role of emotional functioning.","volume":"49","author":"Emery","year":"2025","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"yoi250050r25","volume-title":"Global Appraisal of Individual Needs: Administration Guide for the GAIN and Related Measures","author":"Dennis","year":"2008"},{"key":"yoi250050r26","volume-title":"Structured Clinical Interview for DSM-5\u2014Research Version","author":"First","year":"2015"},{"key":"yoi250050r27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4612-0357-5_3","volume-title":"Measuring Alcohol Consumption: Psychosocial and Biochemical Methods","author":"Sobell","year":"1992"},{"key":"yoi250050r36","year":"2021"},{"key":"yoi250050r2","doi-asserted-by":"crossref","unstructured":"Garnett? MF, Mini\u00f1o? AM. Drug overdose deaths in the United States, 2003-2023. NCHS Data Brief. 2024:1-12. https:\/\/stacks.cdc.gov\/view\/cdc\/170565","DOI":"10.15620\/cdc\/170565"},{"key":"yoi250050r3","unstructured":"Substance Abuse and Mental Health Services Administration; Office of the Surgeon General. Facing addiction in America: the Surgeon General\u2019s report on alcohol, drugs, and health. US Department of Health and Human Services; 2016. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK424857\/"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2839605\/jamapsychiatry_eddie_2025_oi_250050_1764029661.75258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:00:38Z","timestamp":1764777638000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2839605"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.2700","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}